Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF)'s James Lanthier and Joseph Araujo tell Proactive talk to Proactive about its collaboration with McQuade Center for Strategic Research and Development, LLC (MSRD)— a member of the global Otsuka family of pharmaceutical companies— to develop psychedelic medicine.
MSRD has made $5 million strategic investment to support the discovery and development of novel chemical entity assets of Mindset.